Cargando…
Changes in Sensitivity of Reward and Motor Behavior to Dopaminergic, Glutamatergic, and Cholinergic Drugs in a Mouse Model of Fragile X Syndrome
Fragile X syndrome (FXS) is a leading cause of intellectual disability. FXS is caused by loss of function of the FMR1 gene, and mice in which Fmr1 has been inactivated have been used extensively as a preclinical model for FXS. We investigated the behavioral pharmacology of drugs acting through dopam...
Autores principales: | Fish, Eric W., Krouse, Michael C., Stringfield, Sierra J., DiBerto, Jeffrey F., Robinson, J. Elliott, Malanga, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799757/ https://www.ncbi.nlm.nih.gov/pubmed/24205018 http://dx.doi.org/10.1371/journal.pone.0077896 |
Ejemplares similares
-
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021) -
Modulation of striatal glutamatergic, dopaminergic and cholinergic neurotransmission pathways concomitant with motor disturbance in rats with kaolin-induced hydrocephalus
por: Chen, Li-Jin, et al.
Publicado: (2022) -
Continuous cholinergic-dopaminergic updating in the nucleus accumbens underlies approaches to reward-predicting cues
por: Skirzewski, Miguel, et al.
Publicado: (2022) -
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013) -
Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling
por: Martín, Abraham, et al.
Publicado: (2018)